ited in their exercise capacity [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12]. Although exercise Background. Exercise capacity increases significantly soon
coids, on muscle function and structure is well docuResults. Compared to those maintained on steroids, the stemented by Horber et al [19, 20] . It is unclear whether roid withdrawal group showed greater gains in VO 2peak (P ϭ 0.05) and quadriceps peak torque (P ϭ 0.05) and greater gains the absence of steroids from maintenance immunosupin the vitality score and the Physical Composite Scale on the pressive regimens improve exercise capacity, muscle struc-SF-36 questionnaire (P Ͻ 0.05). At 1 year, all patients had ture, or muscle function. typically are the first affected, demonstrating the first Conclusion. We conclude that prednisone is not the cause signs of weakness during climbing stairs and rising from for increased body fat following transplantation; however, it chairs. Quadriceps strength is markedly reduced in both may contribute to lower spontaneous improvements in exercise kidney and heart transplant recipients [16, 20, 21] and capacity possibly by limiting increases in muscle strength. The low exercise capacity in all transplant recipients studied at 1 reported to be 80% [20] and 69% [22] of untrained sedyear suggests a need for exercise training to optimize physical entary control subjects. The atrophy of skeletal muscle functioning following transplant.
with administration of glucocorticoids is related to increased amino acid efflux and decreased rates of protein synthesis. Additionally, glucocorticoids may also reduce overall physical functioning and quality of life [21] . Maintenance steroid therapy may attenuate improvements in [27] . more specific immunosuppression provides the opportunity to withdraw patients from prednisone following Prednisone Withdrawal Protocol transplant and offers the promise of achieving normal levels of fitness.
A total of 36 transplant recipients and 15 sedentary control subjects were recruited into the study. The immuThe purpose of this study is to compare health-related fitness (cardiorespiratory fitness, muscle strength, and nosuppression protocol was as follows. All patients (in both groups) received basliximab (Simulect, Novartis body composition) and quality of life over the first year following renal transplantation in patients with rapid elimPharmaceuticals, East Hanover, NJ, USA) (20 mg intravenously) on days 0 and 4, Cyclosporin (Neoral, Noination of steroids with recipients managed with a standard immunosuppression regimen that includes prednisone.
vartis Pharmaceuticals) (4 to 5 mg/kg orally) twice daily starting postoperative day 1 and mycophenolate mofetil (Cellcept, Roche Laboratories, Nutley, NJ, USA) (1 g METHODS orally preoperatively, then 1.0 to 1.5 g orally twice daily Subjects starting postoperative day 1). Prednisone was given to all patients at the following doses postoperatively: day 0, Kidney transplant recipients were recruited from the population of approximately 290 patients per year trans-500 mg methylprednisolone (Solumedrol) intravenously; day 1, 250 mg Solumedrol intravenously; and day 2, 125 planted at the University of California, San Francisco (UCSF). All patients were unsensitized recipients of first mg Solumedrol intravenously. Patients randomized into rapid elimination of steroids were decreased to 30 mg cadaveric, living related, or living unrelated donor renal transplants. Sedentary controls were recruited from the at day 4 and were withdrawn at day 5. Those randomized into standard prednisone maintenance therapy were tahospital staff and the larger community. Recruitment attempted to match controls to the patients for age and pered to 20 to 30 mg/day of prednisone over day 4 to day 20. From day 21 to day 90, they were tapered in activity (i.e., all were physically inactive).
Patients were a part of a larger study being conducted their final prednisone dose that ranged from 5 to 10 mg/ day. This was a standard taper of 5 mg decrease every at UCSF studying the efficacy of steroid-free maintenance immunosuppression regimens. This study randomother week with the final dose determined primarily by body weight. Maintenance immunosuppression for both ly assigned patients to one of two groups: (1) induction therapy with an interleukin-2 (IL-2) inhibitor (Simugroups included standard CellCept dosing (2 to 3 g/day) and Neoral to maintain trough levels 200 to 250 ng/mL. lect) and rapid elimination of prednisone versus (2) induction therapy and maintenance immunosuppression, Testing including prednisone (see Prednisone Withdrawal Protocol below). The investigators were blinded to the predPatients underwent baseline testing at 3 months posttransplant with repeat testing at 12 months posttransnisone treatment group. The patients signed a separate consent for this study, which was approved by the UCSF plant. The testing was all performed on a single visit and included symptom-limited treadmill exercise testing, Committee on Human Research and the Advisory Committee for the UCSF General Clinical Research, where isokinetic muscle function testing, body composition analysis, and completion of a quality-of-life questionthe studies were completed.
Patients were recruited from the adult renal transplant naire. Muscle biopsies were also performed, the data of which are presented elsewhere [28] . population (i.e., Ͼ18 years of age). Patients were excluded from the rapid elimination of steroid study if they Cardiorespiratory exercise testing. Symptom-limited exercise testing was performed on a treadmill. Oxygen uphad (1) positive T-cell cross match or ABO incompatibility against the donor; (2) previous or multiple organ take (VO 2 ) was determined using a computerized opencircuit spirometry system (Quinton QMC, Bothell, WA, transplants; (3) evidence of transplant rejection; (4) increased risk for graft rejection; or (5) a last panel reactive USA), which was calibrated against known gases prior to each test. Expired respiratory gases were analyzed for antibody level greater than 30% at the time of transplantation. Further exclusion criteria included (1) human volume, fractions of oxygen and carbon dioxide, and oxygen uptake was calculated. Peak oxygen uptake (VO 2peak) immunodeficiency virus (HIV) positivity; (2) active hepatitis; (3) history of malignancy; (4) history of myocardial is expressed in terms relative to body weight (mL O 2 /kg body weight/minute). Age-predicted VO 2peak was deterinfarction within six months prior to the study; or (5) cardiac arrhythmias or other severe or unstable medical mined using formulas reported for sedentary normal individuals by Bruce, Kusumi and Hosmer [29] : VO 2peak conditions. Additional exclusion criteria for the exercise testing study included orthopedic or musculoskeletal disfor males ϭ 57. [27] . A 12-lead electrocardiogram was monitored continuously throughout the test, and exercise three or more times per week for at least 30 minutes per session at an intensity described as "someblood pressure was auscultated at every stage. Ratings of perceived exertion (subjective rating of effort) (RPE) what hard" or greater. All others were classified as inactive. were measured at each stage on a 6 to 20 scale [31] .
Muscle strength. Quadriceps muscle strength was meaData analysis sured using a computerized isokinetic muscle function testing system (Biodex II, New York, NY, USA). The
Descriptive statistics (means, standard deviations) were calculated for all continuous variables. Frequencies were right leg was attached to a dynamometer allowing for isolation of the quadriceps muscle group. The patient generated for other variables. Repeated measures analysis of variance with 1 within factor (time, baseline and 12 performed maximal effort knee extensions (kicks) at a controlled speed of 180Њ per second for 20 repetitions. months) and 1 between factor (group, standard therapy versus steroid withdrawal) was used to determine differVariables measured for analysis were peak torque (the highest torque developed during the set of repetitions ences between the two patient groups over the study time. This analysis allows for testing of the main effects measured in foot pounds) and peak torque per body weight (%).
of group and the main effects of time as well as the interaction of group by time. The group by time interacBody composition. Body composition was determined using dual energy x-ray absorptiometry (DEXA) (Hotion indicates whether the change over time differs between the groups. Univariate analysis of variance was logic QDR 4500, Bedford, MA, USA). The machine was calibrated daily using known phantoms. The software used to compare the two patient groups at 12 months to the control subjects. This analysis was performed using from a full body scan determined bone mineral density (g/cm 2 ), lean body mass (g), and fat mass (g). Percent gender as a covariate since the control group had more females than the patient groups. Statistical significance body fat was calculated from the fat mass and total body weight.
was set at P Ͻ 0.05. Health-related quality of life. The Medical Outcomes Short Form (SF-36) questionnaire was used to evaluate RESULTS self-reported domains of health status [32] . The SF-36 Subjects is a 36-item questionnaire that includes eight components of health-related quality of life: physical functionSince repeated measures analysis of variance only allows for inclusion of those subjects who completed ing (PF), role limitations due to physical health (RP), body pain (BP), general health (GH), vitality (VT), soboth baseline and 12-month testing, 25 transplant recipients are included in the analysis (10 in the rapid eliminacial functioning (SF), role limitations due to emotional health (RE), and mental health (MH). These scales are tion of steroids group and 15 in the standard immunosuppression therapy, including prednisone). Reasons for loss scored from 0 to 100, with higher scores being more positive (i.e., less pain, less limitation). Normalized of subjects at the 12-month testing included four lost to follow-up, one transplant rejection, two with medical scores representing overall physical functioning and mental functioning are calculated from the individual contraindications to testing at 12 months (foot ulcer and chronic hypotension), two with a change to prednisone scales and are presented as the physical composite scale (PCS) and the mental composite scale (MCS). The PCS in the steroid elimination of steroid protocol, two who refused repeat testing. Two diabetic patients were not includes the dimensions of PF, RP, BP, GH, VT, and SF. The MCS is composed of the RE and MH and includes included in the analysis. Fifteen sedentary control subjects completed one testing session for comparative analelements of the GH, VT, and SF scales as well [33] . The scaling of each of these component scores is around 50 ysis. The controls were apparently healthy, with no medical conditions and were not taking any medication. All for normal population values. Questionnaires were given to patients following each testing session to be completed control subjects were sedentary (i.e., not participating in any regular program of exercise). independently and returned by mail.
Activity participation. Activity levels were determined Demographics, laboratory values, and immunosuppression medications for those subjects who completed by self-report and subjects were classified as active or Table 3 ). There was no difference between the patient groups in the increases in fat mass or percent fat over both baseline and 12-month testing and for the sedentary time. At 1 year, both groups of patients had a greater control group are shown in Tables 1 and 2 . The patients fat mass than the controls regardless of steroid usage were not on any medications that would affect the heart (P Ͻ 0.05), even when controlling for gender differences rate response to exercise (specifically ␤ blockers). There between groups. The percent fat was, however, not difwere no differences in age among the three groups and ferent at 1 year between the patients and the controls. no differences in laboratory measures of renal function There were no differences in lean body mass over time between the two patient groups at either baseline or 12 or between the patient groups and controls at 12 months, months.
even when controlled for gender differences.
Body composition
Cardiorespiratory fitness All patients gained weight over the study time period.
Physiologic data at peak exercise are shown in Table  The weight gained predominantly was fat, as indicated 4. There were no differences at baseline between the patient groups in the VO 2peak measurements. Patients by a significant effect of time in total fat mass (F 1,20 ϭ All transplant recipients achieved a perceived exertion a Time ϫ group interaction; P ϭ 0.05 rating (RPE) Ͼ17 (which indicates a subjective maximal effort), which was not different than the subjective efforts of the controls. The respiratory exchange ratio a significant time by group interaction in this measure, (RER) (a physiologic indicator of maximal effort) of indicating that those on standard therapy did not change Ͼ1.0 was also achieved by all patients. However, the over time, but the group maintained on the steroid-free RER was significantly lower in all patients at 1 year regimen increased in muscle strength (F 1,20 ϭ 3.72; P ϭ compared to the controls (P ϭ 0.007) (Table 4) , sug-0.05) ( Table 5 ) (Fig. 1) . The values of peak torque/ body gesting a muscle metabolic limitation to higher levels of weight were not different over time or between groups exercise in the patients. over time. There was no difference in the peak torque Patient heart rates at peak exercise at 1 year were or peak torque/body weight at 1 year between either of significantly lower than the sedentary controls (Table 4) .
the patient groups and the sedentary control subjects, Patients only achieved 75% to 78% of age predicted even when controlled for gender. maximal heart rates, compared to 98% of age-predicted
Health-related quality of life levels for the controls. Patients were not on any medications that would affect heart rate response to exercise.
The scores for the SF-36 questionnaire for the two patient groups are found in Table 6 . There were no Isokinetic muscle function statistically significant differences between the two There were no differences in baseline values for quadgroups in any of the scale scores at baseline. Statistically riceps peak torque at a contraction speed of 180Њ per significant time by group interactions were found in the second. There was a significant increase in this measure vitality score (F 1,19 ϭ 4.02; P ϭ 0.048) and in the Physical Composite Scale (F 1,19 ϭ 3.77; P ϭ 0.05). This indicates in all patients over time (F 1,20 ϭ 3.89; P ϭ 0.05). There was limiting factors [7, 16, 19, 20, 38] .
Role emotional
The weight gain following transplant in both patient found that leisure-time physical activity a difference in the change over time between the two was positively related with percentage of lean body mass groups, with the prednisone withdrawal group having and inversely related with fat mass. We reported that greater gains and the prednisone-treated group actually physically active transplant games participants had sigdeteriorating in some scale scores or showing no change nificantly lower body mass index (BMI) and percent in others. Trends toward increases over time in the stebody fat than did those who were physically inactive roid-elimination group with no change or decreases in [14] . However, in an intent-to-treat exercise intervention the standard therapy group were observed in the followover the first year posttransplant, we did not find any ing scales: bodily pain, role limitations/physical, social differences in body composition between the exercise functioning, and mental composite score. All patients intervention group (33% of whom were not regularly increased in the role physical scale (effect of time, F 1,19 ϭ active) and those in the usual care group [15] . However, 5.14; P ϭ 0.03); however, the increase in the steroid secondary analysis comparing active versus inactive subminimization group was much greater than that of the jects (regardless of randomization groups) showed a sigstandard therapy group. The variation in the scores was nificant trend toward lower BMI and percent fat in the high, thus the time by group interaction was not signifiactive subjects. There was no dietary intervention in that cant. study and caloric intake was not different between the At 12 months posttransplant, the patients had signifigroups. cantly lower scores on all the physical scales, including This study is limited by the small numbers; however, the Physical Composite Scale, compared to the sedentary the observations of statistically significant findings in normal controls (P Ͻ 0.003). The patients did not differ many of the measurements would not be expected in from the controls in any of the mental scale scores except small numbers. Thus, we think that the fact that statistical for social functioning (P Ͻ 0.001) ( Table 6) .
significance was observed in repeated measures analysis of variance was particularly impressive and represent DISCUSSION real difference in exercise responses over the study time between the two groups. We observed similar decreThe use of Simulect induction following renal transplantation has been reported to have no detrimental ments in functioning in usual care group (treated with prednisone) over the first year posttransplant in another minants of VO 2 are actually measured in this patient group, there is no way to determine the relative contribustudy that included a larger number of subjects [15] .
tions of cardiac output and peripheral oxygen utilization. The greater increases in peak VO 2peak in the patients Measurement of health-related quality of life is diffimaintained on the steroid-free regimen suggests that, cult, and often the variation in the scale scores necessifollowing renal transplant, there is a greater spontaneous tates large sample sizes to determine differences between increase in functioning in those not on steroid therapy.
groups. Thus, the striking trends with statistical signifiThe repeated measures analysis of variance is an analysis cance achieved in changes in the vitality score and the of change over time between the two groups. Although overall Physical Composite Scale are impressive, considthere was a trend (NS) for the prednisone withdrawal ering the small numbers of subjects in this study. The group to have lower values at baseline, the trend of those trends of the physical function scale, the bodily pain, maintained on prednisone to deterioration in function and the significant time by group interactions in the vitalover 1 year posttransplant is similar to that reported ity and Physical Composite Scale parallel the physiologic previously in a larger study [15] . Patients maintained on measurements of VO 2peak and muscle strength (i.e., imsteroids showed a similar trend toward deterioration in proved scores in the steroid avoidance group and either functioning over the first year to what we reported in no change or decline in the standard therapy group). the usual care group of the exercise intervention trial Lack of energy is a common complaint in transplant [15] . In that study, the VO 2peak at 1 year was significantly recipients. It may be possible that this overall lack of higher in the exercise group compared to the usual care energy is due to prednisone therapy. Many more subjects group, which had VO 2peak values similar to high-functionare required to confirm the effects of steroid minimizaing dialysis patients. This was also reported in our crosstion on quality of life; however, it appears in this prelimisectional analysis of active versus inactive transplant nary study that overall quality of life is improved with games participants [14] . There was no exercise intervensteroid elimination. tion or exercise recommendations given to any subject Although there were significant gains in cardiorespirain the current study. Only two subjects (both in the tory fitness and muscle strength in those patients not on standard therapy group) reported regular participation prednisone, it should be pointed out that all the patients in physical activity.
remained low in VO 2peak compared to the sedentary norThe greater gains in VO 2peak could be related to an mal controls. The sedentary normal controls achieved improvement in muscle functioning, as evidenced by the 96% Ϯ 18% of their age-predicted maximal capacity, increased quadriceps muscle strength gains in the steroid compared to only 67% in the patients. Thus, although avoidance group. Shephard et al [40] reports that lower significantly greater gains were observed in those not extremity muscle mass is a determinant of external work taking prednisone, all patients remain low in physical performed, thus determining VO 2peak . Although our pafunctioning at 1 year posttransplant. Exercise training tient group as a whole did not have lower lean mass is thus warranted for this patient group for optimizing compared to the control group, there were more males functioning following transplant. Given the greater gains in the patient group than the control group. However, in patients not on prednisone (and actual deterioration when the comparison with the normals was controlled in those in the standard care), it is possible that those for gender, there was no difference in lean body mass patients not taking prednisone will be able to achieve between the patients and the controls. At the 1-year higher levels of cardiorespiratory fitness and muscle testing time, the patients not on prednisone in this study strength with exercise training than those remaining on had significantly larger muscle fiber size (type IIX) than prednisone. those on prednisone [28] and showed ultrastructural differences that would suggest facilitated muscle contrac-CONCLUSION tion and oxygen utilization. It is possible that the microscopic and ultrastructural changes did not show up in Withdrawal of steroid therapy following renal transthe total lean mass measurements, but could contribute plantation results in greater gains in the cardiorespirato the differences observed in muscle strength gains and tory fitness, and muscle strength. It has, however, had VO 2peak .
no effect on body composition. Lifestyle interventions Exercise capacity could also be limited by a blunted such as exercise training and dietary modification, which heart rate response to exercise, which is typically seen are guidelines for reduction of cardiovascular risk, are in patients with ESRD treated with dialysis [3, 4, 8, 17] .
necessary for optimizing health-related fitness following This blunted heart rate response observed in both patient renal transplantation. groups in this study would limit maximal cardiac output, which is one of the primary determinants of oxygen up-ACKNOWLEDGMENTS take as defined by the Fick equation (VO 2 ϭ cardiac This study was funded by Novartis Pharmaceuticals, Inc. This study was carried out in part in the General Clinical Research Center, Moffitt output ϫ arteriovenous O 2 difference). Until all deter-
